Mass Device September 14, 2018
The FDA is hopeful that devices like the new Apple (NSDQ:AAPL) Watch, which is designed to provide on-the-spot electrocardiogram tests and detect atrial fibrillation, will lead to a “reimagination of healthcare delivery,” according to a recent post from agency head Dr. Scott Gottlieb, but whether having that data will improve overall health has yet to be seen.
In its unveiling of the new Apple Watch 4, the Cupertino, Calif.-based tech giant said it worked closely with the FDA to clear the device, which won de novo classification from the federal watchdog.
Gottlieb confirmed that the agency “worked closely with the company as they developed and tested” the products, adding that the agency is hopeful that such devices could help users...
Today's Sponsors
Today's Sponsor